ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,22
-1,51%
Dow Jones
42 732,13
0,80%
DAX
19 906,08
-0,49%
Brent Oil
76,405
-0,13%
Bitcoin
98 346,33
0,04%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE

  6. Hofseth Biocare Asa (0Q6H) Cours

Hofseth Biocare Asa

Hofseth Biocare Asa (0Q6H)

LSE
2,00
0,00
(0,00%)
Fermé 06 Janvier 5:30PM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
2,00
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
0,00
0,00 Fourchette du Jour 0,00
2,00 Plage de 52 semaines 2,00
Cap du marché
790,162M
Clôture Veille
2,00
Ouverture
-
Dernière Transaction
(O)
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
2 618
Actions en circulation
395 081 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-7,41
Bénéfice par action (BPA)
-0,27
Chiffre d'affairess
218,51M
Bénéfice net
-106,68M

À propos de Hofseth Biocare Asa

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.hofsethbiocare.com
Siège social
Alesund, Nor
Fondé
-
Hofseth Biocare Asa est coté dans le secteur Pharmaceutical Preparations de la London Stock Exchange avec le ticker 0Q6H. Le dernier cours de clôture d'Hofseth Biocare Asa était de kr2,00. Au cours de la dernière année, les actions de Hofseth Biocare Asa ont été négociées dans une fourchette de prix de kr 2,00 à kr 2,00.

Hofseth Biocare Asa compte actuellement 395 081 000 actions en circulation. La capitalisation boursière d'Hofseth Biocare Asa est de kr790,16 million. Hofseth Biocare Asa a un ratio cours/bénéfice (ratio PE) de -7.41.

0Q6H Dernières nouvelles

Plus de nouvelles

Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION

Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION Christoph Baldegger, primary insider and member of the Board of Directors in Hofseth BioCare ASA ("HBC") has today purchased 700,000 shares in HBC...

12 Décembre 2024
UK Regulatory

Hofseth Biocare ASA: Commences the project for a second hydrolysis plant in Norway to triple capacity

Hofseth Biocare ASA: Commences the project for a second hydrolysis plant in Norway to triple capacity Hofseth BioCare ASA ("HBC" or the "Company", and together with its consolidated subsidiaries...

05 Décembre 2024
UK Regulatory

Hofseth Biocare ASA: THIRD QUARTER 2024 FINANCIAL REPORT

Hofseth Biocare ASA: THIRD QUARTER 2024 FINANCIAL REPORT HBC had gross operating revenues of NOK 67.9m (49.9m) in the third quarter and NOK 200.6m (171.1m) in the first nine months. The operating...

08 Novembre 2024
UK Regulatory

Hofseth Biocare ASA: CFO RESIGNATION

Hofseth Biocare ASA: CFO RESIGNATION Christel Elise Kanli has decided to step down as Chief Financial Officer (CFO) of Hofseth BioCare ASA (“HBC”) to pursue opportunities outside of the company...

22 Octobre 2024
UK Regulatory

Hofseth Biocare ASA: HBC IMMUNOLOGY COMPLETES IN VIVO DRUG LEAD STUDIES FOR PROSTATE CANCER TREATMENT

Hofseth Biocare ASA: HBC IMMUNOLOGY COMPLETES IN VIVO DRUG LEAD STUDIES FOR PROSTATE CANCER TREATMENT Ålesund, Norway, 8 October 2024. HBC Immunology (HBCI) is pleased to announce the successful...

08 Octobre 2024
UK Regulatory

Hofseth Biocare ASA: SECOND QUARTER AND HALF YEAR 2024 FINANCIAL REPORT

Hofseth Biocare ASA: SECOND QUARTER AND HALF YEAR 2024 FINANCIAL REPORT HBC had gross operating revenues of NOK 80.4m (76.4m) in the second quarter and NOK 132.8m (121.2m) for the half year...

23 Août 2024
UK Regulatory

Hofseth Biocare ASA: GROUNDBREAKING STUDY REVEALS HOFSETH BIOCARE’S FULL SPECTRUM OMEGAS OMEGO SUPPORTS COVID-19 RECOVERY

Hofseth Biocare ASA: GROUNDBREAKING STUDY REVEALS HOFSETH BIOCARE’S FULL SPECTRUM OMEGAS OMEGO SUPPORTS COVID-19 RECOVERY Ålesund, Norway, 14 August, 2024 - Hofseth BioCare (HBC), a leader in...

14 Août 2024
UK Regulatory

Hofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc.

Hofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc. Ålesund, 02.07.24, Hofseth BioCare ASA ("HBC" or the "Company"), a global leader in marine...

02 Juillet 2024
UK Regulatory

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY Hofseth BioCare ASA (HBC) is delighted to announce the appointment of Lithy One-Health Group Technology Co. Ltd...

11 Juin 2024
UK Regulatory

Hofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORT

Hofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORT The first quarter of 2024 continued on the positive trend for HBC. Sales revenues came in at NOK 52m vs NOK 44m last year, a growth of 17...

16 Mai 2024
UK Regulatory
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10022200DE
4002226452DE
120022226182DE
260022211712DE
520022211712DE
156002226602DE
2600022226512DE

0Q6H - Frequently Asked Questions (FAQ)

What is the current Hofseth Biocare Asa share price?
The current share price of Hofseth Biocare Asa is kr 2,00
How many Hofseth Biocare Asa shares are in issue?
Hofseth Biocare Asa has 395 081 000 shares in issue
What is the market cap of Hofseth Biocare Asa?
The market capitalisation of Hofseth Biocare Asa is NOK 790,16M
What is the 1 year trading range for Hofseth Biocare Asa share price?
Hofseth Biocare Asa has traded in the range of kr 2,00 to kr 2,00 during the past year
What is the PE ratio of Hofseth Biocare Asa?
The price to earnings ratio of Hofseth Biocare Asa is -7,41
What is the cash to sales ratio of Hofseth Biocare Asa?
The cash to sales ratio of Hofseth Biocare Asa is 3,62
What is the reporting currency for Hofseth Biocare Asa?
Hofseth Biocare Asa reports financial results in NOK
What is the latest annual turnover for Hofseth Biocare Asa?
The latest annual turnover of Hofseth Biocare Asa is NOK 218,51M
What is the latest annual profit for Hofseth Biocare Asa?
The latest annual profit of Hofseth Biocare Asa is NOK -106,68M
What is the registered address of Hofseth Biocare Asa?
The registered address for Hofseth Biocare Asa is HAVNEGATA 11, ALESUND, 6005
What is the Hofseth Biocare Asa website address?
The website address for Hofseth Biocare Asa is www.hofsethbiocare.com
Which industry sector does Hofseth Biocare Asa operate in?
Hofseth Biocare Asa operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
TCFTheracryf Plc
0,725p
(38,10%)
7,56M
NMTNeometals Ltd
3,50p
(27,27%)
346,81k
SCHOScholium Group Plc
44,00p
(25,71%)
30,65k
FABFusion Antibodies Plc
10,15p
(24,54%)
3,34M
PYXPyx Resources Limited
3,49p
(22,24%)
8,43k
TM1Technology Minerals Plc
0,125p
(-24,24%)
37,21M
QUIZQuiz Plc
0,70p
(-18,60%)
3,67M
SYMESupply@me Capital Plc
0,003p
(-17,81%)
168,35M
OBDOxford Biodynamics Plc
1,20p
(-14,29%)
827,83k
ZENZenith Energy Ltd.
5,25p
(-13,93%)
5,39M
TRPTower Resources Plc
0,0395p
(5,33%)
539,51M
CPXCap-xx Limited
0,1825p
(1,39%)
494M
NTVONativo Resources Plc
0,0019p
(0,00%)
320,16M
DGIDg Innovate Plc
0,0225p
(-13,46%)
208,21M
ENETEthernity Networks Ltd
0,1125p
(2,27%)
207,56M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

LSE
0Q6H
Hofseth Biocare Asa
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés